## LKQ: LKQ Corporation - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.06 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-4.1% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($28.23)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Stephens & Co. | $39 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Stephens & Co. | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.31M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-0.9%)
- Blackrock Inc.: 6.5% (-27.6%)
- Morgan Stanley: 5.2% (-20.0%)
- Nordea Investment Ma: 5.0% (+3.2%)
- Massachusetts Financ: 4.5% (+5.2%)

### Key Risks

1. Long-term trend broken: trading 14.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.06 suggests fair value with growth premium. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.7B |
| Beta | 0.90 |
| 52W Range | $28.13 - $44.82 |
| Short Interest | 6.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.06 |
| Forward P/E | 9.1 |
| Current P/E | 9.7 |
| YoY Growth | 6.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.9% to -0.2% (-4.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. RSI neutral at 50. Elevated volume (4.6x 20MA), institutional activity likely. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.18% (CS: 54) | Neutral |
| RSI_14 | 50.4 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.860x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $29.99
- **Stop Loss:** $28.23 (5.9% risk)
- **Target:** $33.51 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 511
- **Position Value:** $15,324.89
- **Portfolio %:** 15.32%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-19 (Est: $0.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.76 | $0.84 | +11.0% |
| 2025Q2 | $0.92 | $0.87 | -5.8% |
| 2025Q1 | $0.78 | $0.79 | +1.5% |
| 2024Q4 | $0.74 | $0.80 | +7.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*